PPCB
Propanc Biopharma, Inc. Common Stock
NASDAQ: PPCB · HEALTHCARE · BIOTECHNOLOGY
$0.10
+2.40% today
Updated 2026-04-30
Market cap
$2.32M
P/E ratio
0.00
P/S ratio
—
EPS (TTM)
$52.11
Dividend yield
—
52W range
$0 – $11
Volume
3.9M
Propanc Biopharma, Inc. Common Stock (PPCB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-191509.00 | $-1.40M | $-170278.00 | $-128647.00 | $-226442.00 | $-1.43M | $-4.80M | $-2.15M | $-2.18M | $-2.06M | $-1.85M | $-1.15M | $-1.44M | $-1.11M | $-935118.00 | $-405168.00 |
| Capital expenditures | $1.00 | $3504.00 | $2.00 | $3.00 | $2.00 | $3901.00 | $9877.00 | $1.00 | $2.18M | $2873.00 | $1.00 | $4.00 | $4.00 | $1.00 | $2.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $114028.00 | $363455.00 | $888.00 | $237833.00 | $277859.00 | $1.72M | $1.69M | $646.00 | $245145.00 | $300416.00 | $82872.00 | $387139.00 | $141356.00 | $0.00 | $4.62M |
| Free cash flow | $-191510.00 | $-1.40M | $-170280.00 | $-128650.00 | $-226444.00 | $-1.43M | $-4.81M | $-2.15M | $-4.36M | $-2.06M | $-1.85M | $-1.15M | $-1.44M | $-1.11M | $-935120.00 | $-405168.00 |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | $391749.00 | $700340.00 | $466273.00 | $192960.00 | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |